Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2015746362
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015746362
Title / Product Name
PHARMAZEUTISCHE VERBINDUNGEN ALS CHK1-INHIBITOREN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015746362
EP Publication Number
3104860
E-Number
1349239
Language
EN
PCT Number
US15015030
Publication Date
21.12.2016 A
30.12.2020 B1
Registration Date
30.12.2020
AT Publication Date
15.01.2021
Application Date
09.02.2015
Registration Number
-
Priorities
10.02.2014
GB
201402277
24.11.2014
US
201462083687 P
IPC
A61K 31/4965 20060101AFI20170707BHEP
Maximum Duration of Protection
09.02.2035
Owner
Sentinel Oncology Limited
181 Science Park Milton Road
Cambridge Cambridgeshire CB4 0GJ
GB
Representative
No representatives present
Inventor
BOYLE, Robert George
c/o Sentinel Oncology Limited Suite 52 23 Cambridge Science Park
Cambridge, UK CB4 0EY
GB
WALKER, David Winter
c/o Sentinel Oncology Limited Suite 52 23 Cambridge Science Park
Cambridge, UK CB4 0EY
GB
BOYCE, Richard Justin
c/o Sentinel Oncology Limited Suite 52 23 Cambridge Science Park
Cambridge, UK CB4 0EY
GB
PETERSON, Scott
Cascadian Therapeutics, Inc. 2601 Fourth Avenue Suite 500
Seattle, WA 98121
US
FAROUZ, Francine
Cascadian Therapeutics, Inc. 2601 Fourth Avenue Suite 500
Seattle, WA 98121
US
VO, Cong Hung
Cascadian Therapeutics, Inc. 2601 Fourth Avenue Suite 500
Seattle, WA 98121
US